Kronos Bio Inc.

NASDAQ: KRON · Real-Time Price · USD
0.88
0.01 (1.49%)
At close: Jun 20, 2025, 9:43 AM

Kronos Bio Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-64.49M -86.08M -85.59M -102.85M -116.39M -112.67M -119.14M -120.02M -123.18M -133.2M -163.76M -165.1M -161.25M -151.08M -121.9M -128.01M -107.53M
Depreciation & Amortization
664K 1.72M 1.78M 2.68M 2.84M 2.14M 2.23M 2.29M 2.28M 2.27M 2.24M 2.19M 2.09M 1.98M 1.73M 1.4M 1.12M
Stock-Based Compensation
6.03M 9.22M 12.73M 17M 21.7M 24.98M 27.5M 28.66M 29.96M 31.14M 30.86M 30.54M 28.76M 26.21M 20.83M 14.94M 8.8M
Other Working Capital
-3.92M -6.79M -2.49M -13.1M -12.48M 10.02M 9.47M 11.92M 15.35M 2.15M 1.49M 1.38M -240K 1.57M 3.77M 3.87M 5.03M
Other Non-Cash Items
7.99M 19.5M 12.6M 25.14M 25.4M 10.36M 1.11M 627K 839K 2.69M 3.56M 3.83M 3.51M 2.59M 16.12M 39.26M 39.68M
Deferred Income Tax
n/a n/a -9.33M -10.7M -9.27M -9.27M 66K 1.43M n/a n/a 822K 1.92M 3.05M 4M 3.4M 2.34M 1.21M
Change in Working Capital
-4.58M -5.27M -5.29M -14.58M -16.29M 5.88M 12.14M 11.11M 16.71M 6.18M -644K 1.96M 1.43M -1.62M 4.8M 4.9M 6.88M
Operating Cash Flow
-54.38M -65.44M -77.62M -87.84M -96.53M -78.58M -76.09M -75.89M -73.39M -90.93M -126.92M -124.67M -122.41M -117.92M -75.03M -65.18M -49.84M
Capital Expenditures
3K -4K -31K -252K -560K -679K -700K -559K -337K -577K -1M -1.86M -3.12M -4.26M -7.46M -10.7M -10.45M
Cash Acquisitions
n/a n/a -31.59M -67.59M -73.28M -67.05M -67.24M -34.42M 11.9M 5.67M 37.46M 40.64M n/a n/a n/a n/a n/a
Purchase of Investments
-44.93M -89.23M -120.92M -127.79M -159.12M -212.96M -230.76M -291.33M -375.18M -367.12M -321.3M -252.66M -146.22M -177.73M -351.74M -362.37M -353.08M
Sales Maturities Of Investments
144.44M 174.67M 215.58M 241.34M 238.17M 280M 298M 325.75M 363.27M 335.48M 297.09M 276.29M 274.88M 245.72M 225.42M 168.41M 109.83M
Other Investing Acitivies
n/a 5.78M 37.37M 73.37M 79.05M 67.05M 67.24M 34.42M -11.9M -31.64M -24.21M 23.63M 128.66M 67.98M -126.32M -193.95M -243.25M
Investing Cash Flow
99.51M 85.44M 94.64M 113.3M 78.49M 66.37M 66.54M 33.86M -12.24M -32.22M -25.21M 21.78M 125.54M 63.72M -133.78M -204.66M -253.69M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -5K -13K 151.25M 151.25M
Common Stock Repurchased
162K 162K 700K 538K 538K 538K -716K -716K -716K -716K 521K 521K 521K 521K n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
245K 245K 354K 355K 567K 567K -340K 288K 322K 851K 2.62M 3.37M 4.4M 3.88M 5.72M 2.09M 645K
Financial Cash Flow
245K 245K 354K 355K 567K 567K -340K 288K 322K 851K 2.62M 3.37M 4.4M 4.46M 269.61M 417.52M 416.19M
Net Cash Flow
45.38M 20.25M 17.36M 25.81M -17.47M -11.65M -9.88M -41.74M -85.31M -122.3M -149.51M -99.52M 7.53M -49.74M 60.8M 147.69M 112.65M
Free Cash Flow
-54.38M -65.44M -77.66M -88.09M -97.09M -79.26M -76.79M -76.45M -73.73M -91.5M -127.92M -126.52M -125.53M -122.18M -82.5M -75.88M -60.29M